Literature DB >> 21040417

Maximum conservative management for patients with chronic kidney disease stage 5.

Aine Burns1, Andrew Davenport.   

Abstract

Following the expansion of dialysis services for patients with chronic kidney disease, an increasing number of elderly patients with varying degrees of frailty and additional comorbidities have been offered treatment. Life expectancy is somewhat limited in this group of patients, and initiation of dialysis may not necessarily improve quality of life. As such, an increasing number of centers are offering conservative care for patients who have made an informed decision not to have dialysis. As conservative care includes active treatment of anemia, volume overload, blood pressure control, and management of uremic symptoms, including pruritus, we term this approach as maximal conservative management of chronic kidney disease. We describe our experience of maximum conservative management, which although may not prolong life, can maintain the quality of life and functional ability until the final illness in the majority of patients. Although these patients do not go to the hospital on a regular basis, coordinated support from the hospital, the community, and the care giver/relative is required for successful care of the patient. Appropriate end of life planning can then be made according to the wishes of the patient.
© 2010 The Authors. Hemodialysis International © 2010 International Society for Hemodialysis.

Entities:  

Mesh:

Year:  2010        PMID: 21040417     DOI: 10.1111/j.1542-4758.2010.00488.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  13 in total

Review 1.  Renal replacement therapy in the elderly population.

Authors:  Joseph R Berger; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

2.  Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease.

Authors:  Rachael L Morton; Paul Snelling; Angela C Webster; John Rose; Rosemary Masterson; David W Johnson; Kirsten Howard
Journal:  CMAJ       Date:  2012-02-06       Impact factor: 8.262

3.  Older adults with CKD and acute kidney failure: do we know enough for critical shared decision making?

Authors:  Amy W Williams
Journal:  J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 10.121

4.  Provider Knowledge, Attitudes, and Practices Surrounding Conservative Management for Patients with Advanced CKD.

Authors:  Sanah Parvez; Khaled Abdel-Kader; V Shane Pankratz; Mi-Kyung Song; Mark Unruh
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-15       Impact factor: 8.237

5.  Factors associated with initiation of chronic renal replacement therapy for patients with kidney failure.

Authors:  Labib I Faruque; Brenda R Hemmelgarn; Natasha Wiebe; Braden J Manns; Pietro Ravani; Scott Klarenbach; Rick Pelletier; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

6.  Choosing wisely and beyond: shared decision making and chronic kidney disease.

Authors:  Phillip Tuso
Journal:  Perm J       Date:  2013

7.  Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5.

Authors:  Roman Reindl-Schwaighofer; Alexander Kainz; Michael Kammer; Alexandra Dumfarth; Rainer Oberbauer
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

8.  Development of a mortality score to assess risk of adverse drug reactions among hospitalized patients with moderate to severe chronic kidney disease.

Authors:  Monica Danial; Mohamed Azmi Hassali; Ong Loke Meng; Yoon Chee Kin; Amer Hayat Khan
Journal:  BMC Pharmacol Toxicol       Date:  2019-07-08       Impact factor: 2.483

Review 9.  Palliative dialysis: a change of perspective.

Authors:  Thiago Gomes Romano; Henrique Palomba
Journal:  J Clin Med Res       Date:  2014-05-22

10.  Understanding by older patients of dialysis and conservative management for chronic kidney failure.

Authors:  Sarah Tonkin-Crine; Ikumi Okamoto; Geraldine M Leydon; Fliss E M Murtagh; Ken Farrington; Fergus Caskey; Hugh Rayner; Paul Roderick
Journal:  Am J Kidney Dis       Date:  2014-10-08       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.